Sotera Health Co
$ 17.70
0.00%
26 Dec - close price
- Market Cap 5,028,463,000 USD
- Current Price $ 17.70
- High / Low $ 17.73 / 17.61
- Stock P/E 88.50
- Book Value 1.94
- EPS 0.20
- Next Earning Report 2026-03-03
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.08 %
- ROE 0.11 %
- 52 Week High 17.82
- 52 Week Low 9.53
About
Sotera Health Company (SHC) is a prominent provider of sterilization, laboratory testing, and advisory services tailored to the medical devices, pharmaceuticals, and food sectors across the Americas, Europe, and Asia. Based in Broadview Heights, Ohio, the company employs advanced technologies to enhance product safety and regulatory compliance, ensuring high-quality solutions for its diverse clientele. With a steadfast commitment to improving safety standards, Sotera Health serves as a trusted partner in global health solutions, solidifying its competitive edge in the industry.
Analyst Target Price
$18.93
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-04 | 2025-08-08 | 2025-04-30 | 2025-02-25 | 2024-11-05 | 2024-08-05 | 2024-05-02 | 2024-02-27 | 2023-11-01 | 2023-08-03 | 2023-05-03 | 2023-02-28 |
| Reported EPS | 0.26 | 0.2 | 0.14 | 0.21 | 0.17 | 0.19 | 0.13 | 0.26 | 0.21 | 0.21 | 0.13 | 0.25 |
| Estimated EPS | 0.2167 | 0.17 | 0.1218 | 0.2019 | 0.18 | 0.16 | 0.13 | 0.26 | 0.2 | 0.18 | 0.14 | 0.22 |
| Surprise | 0.0433 | 0.03 | 0.0182 | 0.0081 | -0.01 | 0.03 | 0 | 0 | 0.01 | 0.03 | -0.01 | 0.03 |
| Surprise Percentage | 19.9815% | 17.6471% | 14.9425% | 4.0119% | -5.5556% | 18.75% | 0% | 0% | 5% | 16.6667% | -7.1429% | 13.6364% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-03-03 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 0.2416 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: SHC
2025-12-25 10:09:07
Sotera Health Co (SHC) stock has reached a new 52-week high of $17.79, reflecting a 28.49% increase over the past year and a 54.89% return in six months. This surge is supported by strong investor confidence, positive market conditions, and a "GOOD" financial health score, with analysts anticipating net income growth. The company also recently reported strong Q3 2025 financial results, exceeding analyst expectations, and announced a secondary offering.
2025-12-25 09:09:25
Sotera Health (SHC) saw its stock rise by 5.3% after reporting a strong quarter with revenues up 9.1% year-on-year, beating analyst estimates, and achieving double-digit adjusted EBITDA growth alongside 150 basis points of margin expansion. These results highlight significant efficiency gains in its sterilization and lab testing operations. Despite these improvements, the company still faces risks related to ongoing ethylene oxide (EO) regulation and legal exposure, which management is addressing through elevated capital expenditure.
2025-12-24 17:09:54
Sotera Health Co's stock reached a new 52-week high of $17.79, reflecting strong investor confidence and positive market conditions. The company has seen significant stock price increases over the past year and six months, with analysts expecting net income growth. Recent news also highlights strong Q3 2025 financial results and positive analyst ratings.
2025-12-24 10:08:53
Sotera Health Company (NASDAQ:SHC) has received an average "Moderate Buy" rating from seven brokerages, with a mean 12-month price target of $17.80. This sentiment comes despite significant insider selling totaling approximately $471.8 million in the last three months, though insiders still hold a substantial 55.12% of the stock. The company recently surpassed Q3 earnings expectations and provided optimistic FY2025 guidance.
2025-12-19 11:08:49
William Blair analyst Max Smock has initiated coverage on Sotera Health Company (SHC.US) with a 'buy' rating. Smock has a 68.2% success rate and a 6.7% average return over the past year, according to TipRanks data. The rating reflects a positive outlook on Sotera Health Company's stock performance.
2025-12-18 19:09:45
William Blair initiated coverage on Sotera Health (NYSE: SHC) with an Outperform rating, noting the company appears undervalued despite its strong market position and best-in-class margins. The analyst believes easing ethylene oxide litigation risks and improving free cash flow will lead to a re-rating of the stock, predicting approximately 45% upside over the next two years. Sotera Health's integrated sterilization platform and sticky customer base are highlighted as key strengths.
